| # | Drug | Count |
|---|---|---|
| 0 | CABAZITAXEL | 67 |
| 1 | CARBOPLATIN | 32 |
| 2 | TACROLIMUS | 27 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 25 |
| 4 | TACROLIMUS OINTMENT 0.1% | 25 |
| 5 | TRASTUZUMAB | 25 |
| 6 | DOCETAXEL | 23 |
| 7 | DOCETAXEL ANHYDROUS | 23 |
| 8 | PERTUZUMAB | 23 |
| 9 | PREDNISONE | 23 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CABAZITAXEL | 67 | 0.0191 |
| 1 | KETAMINE HYDROCHLORIDE | 10 | 0.0019 |
| 2 | BEVACIZUMAB-BVZR | 1 | 0.0014 |
| 3 | DAUNORUBICIN HYDROCHLORIDE | 2 | 0.0012 |
| 4 | PERTUZUMAB | 23 | 0.0008 |
| 5 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 2 | 0.0008 |
| 6 | CHLORZOXAZONE | 1 | 0.0008 |
| 7 | CARMUSTINE | 3 | 0.0006 |
| 8 | GEMTUZUMAB OZOGAMICIN | 2 | 0.0005 |
| 9 | PITOLISANT HYDROCHLORIDE | 1 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthracycline Topoisomerase Inhibitor [EPC] | 2 | 0.0008 |
| 1 | CD33-directed Immunoconjugate [EPC] | 2 | 0.0005 |
| 2 | HER2/neu Receptor Antagonist [EPC] | 25 | 0.0003 |
| 3 | CD30-directed Immunoconjugate [EPC] | 3 | 0.0003 |
| 4 | Gadolinium-based Contrast Agent [EPC] | 1 | 0.0002 |
| 5 | Microtubule Inhibitor [EPC] | 32 | 0.0002 |
| 6 | Prostaglandin E1 Analog [EPC] | 3 | 0.0002 |
| 7 | Autologous Cellular Immunotherapy [EPC] | 1 | 0.0002 |
| 8 | CD52-directed Cytolytic Antibody [EPC] | 3 | 0.0002 |
| 9 | Alkaloid [EPC] | 4 | 0.0002 |